Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Stations X's GenePool; DNAnexus' PaaS

Premium

Station X has launched GenePool, a cloud-based software application to manage, analyze, and communicate genomic and clinical information. Users can analyze sequence information from both DNA and RNA to identify biomarkers. The software has a web browser interface. Users can do analysis comparisons between tumor and normal genomes, analyses comparing responders and non-responders, and trio-based analyses for genetic diseases, among other applications.


DNAnexus has launched PaaS, or platform-as-a-service to enable clinical testing laboratories to move their analysis pipelines into the cloud using their own algorithms as well as industry tools and resources to create customized workflows. According to the company, the platform enables genomic research enterprises to expand their data analysis and storage infrastructure needs into the cloud and transform large capital expenditures into transparent operating expenses.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.